Correlation Between Apellis Pharmaceuticals and Arcus Biosciences
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Arcus Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Arcus Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Arcus Biosciences, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Arcus Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Arcus Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Arcus Biosciences.
Diversification Opportunities for Apellis Pharmaceuticals and Arcus Biosciences
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Apellis and Arcus is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Arcus Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcus Biosciences and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Arcus Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcus Biosciences has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Arcus Biosciences go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Arcus Biosciences
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to under-perform the Arcus Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Apellis Pharmaceuticals is 1.02 times less risky than Arcus Biosciences. The stock trades about -0.01 of its potential returns per unit of risk. The Arcus Biosciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1,557 in Arcus Biosciences on September 1, 2024 and sell it today you would lose (13.00) from holding Arcus Biosciences or give up 0.83% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Arcus Biosciences
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Arcus Biosciences |
Apellis Pharmaceuticals and Arcus Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Arcus Biosciences
The main advantage of trading using opposite Apellis Pharmaceuticals and Arcus Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Arcus Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcus Biosciences will offset losses from the drop in Arcus Biosciences' long position.| Apellis Pharmaceuticals vs. Tff Pharmaceuticals | Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. Inhibrx | Apellis Pharmaceuticals vs. Enliven Therapeutics |
| Arcus Biosciences vs. Cullinan Oncology LLC | Arcus Biosciences vs. Annexon | Arcus Biosciences vs. Structure Therapeutics American | Arcus Biosciences vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |